News

News and features

Sign up for email alerts of latest news, events, new funding opportunities and more.

Impact story

MRC-funded research influences 2015 NICE Dementia Guidelines

21 Aug 2017

The MRC Cognitive Function and Ageing Study (CFAS) has led to important insights into the association of lifestyle factors with the risk of cognitive impairment. In 2015 the findings from this important study helped predict future demand for long term care and likely associated costs, thereby influencing the 2015 NICE Dementia Guidelines. 

Impact story

Modelling spread of antibiotic resistance helps develop effective hospital controls

11 Jul 2017

In 2015, MRC-funded scientists designed powerful mathematical modelling techniques to analyse the spread of antibiotic resistant bacteria in a hospital setting. This work has allowed scientists to evaluate the effectiveness of infection control measures within the hospital, helping to implement safer protocols. 

Impact story

Learning about human infections from studies of animal disease transmission

11 Jul 2017

MRC-funded research into how antibiotic resistance can jump from farm animals to humans in 2015 highlighted potential new transmission routes to infections. This work has led to a new approach to re-sensitising resistant bacteria to existing antibiotics as well as new diagnostic technology.

Impact story

AMR research leads to China banning antibiotic from animal feed

11 Jul 2017

In 2015, MRC-funded scientists identified a new form of a gene in China which affords protective resistance to the last-resort antibiotic, colistin. By working closely with the Chinese government, the team was able to instigate an unprecedented policy change in 2016, designed to combat the spread of antibiotic resistance.

News

Artificial bile ducts transplanted into mice

6 Jul 2017

MRC-funded scientists have grown and transplanted artificial human bile ducts into mice, paving the way for future treatment of childhood liver diseases which often require liver transplant.

Impact story

MRC-funded supercomputer 'eMedLab' is an invaluable to researchers using Big Data

22 Jun 2017

In 2014, the MRC funded the development of eMedLab, a high performance cloud-computing platform with a focus on three disease areas. In just a short time, this platform is proving invaluable to researchers studying cancer, heart disease, and rare diseases. In March 2017, eMedLab was awarded the Best Public Sector Project at the annual UK Cloud Awards